Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Trophoblast Glycoprotein (TPGB/5T4) in Human Placenta: Expression, Regulation, and Presence in Extracellular Microvesicles and Exosomes.

Alam SMK, Jasti S, Kshirsagar SK, Tannetta DS, Dragovic RA, Redman CW, Sargent IL, Hodes HC, Nauser TL, Fortes T, Filler AM, Behan K, Martin DR, Fields TA, Petroff BK, Petroff MG.

Reprod Sci. 2018 Feb;25(2):185-197. doi: 10.1177/1933719117707053. Epub 2017 May 8.

PMID:
28481180
2.

Immune response to a model shared placenta/tumor-associated antigen reduces cancer risk in parous mice.

Jasti S, Farahbakhsh M, Nguyen S, Petroff BK, Petroff MG.

Biol Reprod. 2017 Jan 1;96(1):134-144. doi: 10.1095/biolreprod.116.144907.

PMID:
28395331
3.

ASHP Guidelines on Evaluating and Using Home or Alternate-Site Infusion Service Providers.

Petroff B, Johnson C.

Am J Health Syst Pharm. 2016 Jun 15;73(12):922-6. doi: 10.2146/ajhp151013. Review. No abstract available.

PMID:
27261242
4.

The combined effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and the phytoestrogen genistein on steroid hormone secretion, AhR and ERβ expression and the incidence of apoptosis in granulosa cells of medium porcine follicles.

Piasecka-Srader J, Sadowska A, Nynca A, Orlowska K, Jablonska M, Jablonska O, Petroff BK, Ciereszko RE.

J Reprod Dev. 2016;62(1):103-13. doi: 10.1262/jrd.2015-125. Epub 2015 Nov 14.

5.

Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal Women.

Fabian CJ, Kimler BF, Phillips TA, Box JA, Kreutzjans AL, Carlson SE, Hidaka BH, Metheny T, Zalles CM, Mills GB, Powers KR, Sullivan DK, Petroff BK, Hensing WL, Fridley BL, Hursting SD.

Cancer Prev Res (Phila). 2015 Oct;8(10):912-21. doi: 10.1158/1940-6207.CAPR-14-0335.

6.

Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.

Fabian CJ, Kimler BF, Zalles CM, Phillips TA, Metheny T, Petroff BK, Havighurst TC, Kim K, Bailey HH, Heckman-Stoddard BM.

Cancer Prev Res (Phila). 2015 Dec;8(12):1146-55. doi: 10.1158/1940-6207.CAPR-15-0109. Epub 2015 Sep 21.

7.

Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women.

Fabian CJ, Kimler BF, Phillips TA, Nydegger JL, Kreutzjans AL, Carlson SE, Hidaka BH, Metheny T, Zalles CM, Mills GB, Powers KR, Sullivan DK, Petroff BK, Hensing WL, Fridley BL, Hursting SD.

Cancer Prev Res (Phila). 2015 Oct;8(10):922-31. doi: 10.1158/1940-6207.CAPR-14-0336. Epub 2015 Aug 14.

8.

Effects of Flaxseed Lignan Secoisolariciresinol Diglucosideon Preneoplastic Biomarkers of Cancer Progression in a Model of Simultaneous Breast and Ovarian Cancer Development.

Delman DM, Fabian CJ, Kimler BF, Yeh H, Petroff BK.

Nutr Cancer. 2015;67(5):857-64. doi: 10.1080/01635581.2015.1042549. Epub 2015 May 26.

9.

Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries.

Piasecka-Srader J, Blanco FF, Delman DH, Dixon DA, Geiser JL, Ciereszko RE, Petroff BK.

Biol Reprod. 2015 May;92(5):132. doi: 10.1095/biolreprod.114.126136. Epub 2015 Apr 1.

10.

Challenges and Potential for Ovarian Preservation with SERMs.

Ting AY, Petroff BK.

Biol Reprod. 2015 May;92(5):133. doi: 10.1095/biolreprod.115.128207. Epub 2015 Mar 25. Review.

11.

Ovarian autoimmune disease: clinical concepts and animal models.

Warren BD, Kinsey WK, McGinnis LK, Christenson LK, Jasti S, Stevens AM, Petroff BK, Petroff MG.

Cell Mol Immunol. 2014 Nov;11(6):510-21. doi: 10.1038/cmi.2014.97. Epub 2014 Oct 20. Review.

12.

The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer.

Sharma P, Stecklein SR, Kimler BF, Sethi G, Petroff BK, Phillips TA, Tawfik OW, Godwin AK, Jensen RA.

J Cancer Ther Res. 2014 Mar 19;3(2):1-11. doi: 10.7243/2049-7962-3-2.

13.

ASHP guidelines on home infusion pharmacy services.

Petroff BJ, Filibeck D, Nowobilski-Vasilios A, Olsen RS, Rollins CJ, Johnson C.

Am J Health Syst Pharm. 2014 Feb 15;71(4):325-41. doi: 10.2146/sp140004. No abstract available.

PMID:
24481158
14.

Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.

Fabian CJ, Kimler BF, Donnelly JE, Sullivan DK, Klemp JR, Petroff BK, Phillips TA, Metheny T, Aversman S, Yeh HW, Zalles CM, Mills GB, Hursting SD.

Breast Cancer Res Treat. 2013 Nov;142(1):119-32. doi: 10.1007/s10549-013-2730-8. Epub 2013 Oct 19.

15.

Assessment of RNA in human breast tissue sampled by random periareolar fine needle aspiration and ductal lavage and processed as fixed or frozen specimens.

Phillips TA, Fabian CJ, Kimler BF, Petroff BK.

Reprod Biol. 2013 Mar;13(1):75-81. doi: 10.1016/j.repbio.2013.01.179. Epub 2013 Feb 19.

PMID:
23522074
16.

A case for combined ovarian and breast cancer prevention.

Petroff BK.

Med Hypotheses. 2012 Oct;79(4):549-51. doi: 10.1016/j.mehy.2012.07.018. Epub 2012 Aug 4.

PMID:
22867867
17.

The autoimmune regulator prevents premature reproductive senescence in female mice.

Jasti S, Warren BD, McGinnis LK, Kinsey WH, Petroff BK, Petroff MG.

Biol Reprod. 2012 Apr 12;86(4):110. doi: 10.1095/biolreprod.111.097501. Print 2012 Apr.

18.

The effect of tumor necrosis factor α (TNFα), interleukin 1β (IL1β) and interleukin 6 (IL6) on endometrial PGF2α synthesis, metabolism and release in early-pregnant pigs.

Franczak A, Zmijewska A, Kurowicka B, Wojciechowicz B, Petroff BK, Kotwica G.

Theriogenology. 2012 Jan 1;77(1):155-65. doi: 10.1016/j.theriogenology.2011.07.029. Epub 2011 Sep 14.

PMID:
21924479
19.

The aryl hydrocarbon receptor agonist 2,3,7,8-tetrachloro-dibenzo-p-dioxin (TCDD) alters early embryonic development in a rat IVF exposure model.

Petroff BK, Valdez KE, Brown SB, Piasecka J, Albertini DF.

Reprod Toxicol. 2011 Nov;32(3):286-92. doi: 10.1016/j.reprotox.2011.07.005. Epub 2011 Jul 30.

20.

In vitro effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on ovarian, pituitary, and pineal function in pigs.

Jablonska O, Piasecka J, Petroff BK, Nynca A, Siawrys G, Wąsowska B, Zmijewska A, Lewczuk B, Ciereszko RE.

Theriogenology. 2011 Sep 15;76(5):921-32. doi: 10.1016/j.theriogenology.2011.04.023. Epub 2011 Jun 25.

PMID:
21705052
21.

Use of hormonal protection for chemotherapy-induced gonadotoxicity.

Kim SS, Lee JR, Jee BC, Suh CS, Kim SH, Ting A, Petroff B.

Clin Obstet Gynecol. 2010 Dec;53(4):740-52. doi: 10.1097/GRF.0b013e3181f96cb1. Review.

PMID:
21048441
22.

Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.

Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Petroff BK, Khan QJ, Sharma P, Setchell KD, Zhao X, Phillips TA, Metheny T, Hughes JR, Yeh HW, Johnson KA.

Cancer Prev Res (Phila). 2010 Oct;3(10):1342-50. doi: 10.1158/1940-6207.CAPR-10-0022. Epub 2010 Aug 19.

23.

Tamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat.

Ting AY, Petroff BK.

J Assist Reprod Genet. 2010 Nov;27(11):591-7. doi: 10.1007/s10815-010-9463-y. Epub 2010 Aug 14.

24.

The environmental toxicant 2,3,7,8-tetrachlorodibenzo-p-dioxin disturbs the establishment and maintenance of cell polarity in preimplantation rat embryos.

Hutt KJ, Shi Z, Petroff BK, Albertini DF.

Biol Reprod. 2010 May;82(5):914-20. doi: 10.1095/biolreprod.109.081109. Epub 2010 Jan 20.

25.

Temporal and anatomical sensitivities to the aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin leading to premature acyclicity with age in rats.

Jablonska O, Shi Z, Valdez KE, Ting AY, Petroff BK.

Int J Androl. 2010 Apr;33(2):405-12. doi: 10.1111/j.1365-2605.2009.01031.x. Epub 2010 Jan 4.

26.
27.

Effect of chronic exposure to the aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin in female rats on ovarian gene expression.

Valdez KE, Shi Z, Ting AY, Petroff BK.

Reprod Toxicol. 2009 Jul;28(1):32-7. doi: 10.1016/j.reprotox.2009.03.004. Epub 2009 Mar 25.

28.

Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases.

Ting AY, Kimler BF, Fabian CJ, Petroff BK.

Cancer Prev Res (Phila). 2008 Dec;1(7):546-53. doi: 10.1158/1940-6207.CAPR-08-0015.

29.

The environmental toxicant 2,3,7,8-tetrachlorodibenzo-p-dioxin disrupts morphogenesis of the rat pre-implantation embryo.

Hutt KJ, Shi Z, Albertini DF, Petroff BK.

BMC Dev Biol. 2008 Jan 2;8:1. doi: 10.1186/1471-213X-8-1.

30.

Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.

Fabian CJ, Kimler BF, Zalles CM, Khan QJ, Mayo MS, Phillips TA, Simonsen M, Metheny T, Petroff BK.

Breast Cancer Res Treat. 2007 Nov;106(1):75-84. Epub 2007 Jan 13.

PMID:
17221152
32.
33.

The effect of progesterone on oxytocin-stimulated intracellular mobilization of Ca2+ and prostaglandin E2 and F2alpha secretion from porcine myometrial cells.

Franczak A, Kurowicka B, Oponowicz A, Petroff BK, Kotwica G.

Prostaglandins Other Lipid Mediat. 2006 Oct;81(1-2):37-44. Epub 2006 Aug 1.

PMID:
16997130
34.

Optimization of estrogen receptor analysis by immunocytochemistry in random periareolar fine-needle aspiration samples of breast tissue processed as thin-layer preparations.

Petroff BK, Clark JL, Metheny T, Xue Q, Kimler BF, Fabian CJ.

Appl Immunohistochem Mol Morphol. 2006 Sep;14(3):360-4.

PMID:
16932030
35.

Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.

Ting AY, Kimler BF, Fabian CJ, Petroff BK.

Carcinogenesis. 2007 Jan;28(1):130-5. Epub 2006 Aug 3.

PMID:
16891317
36.

Expression of enzymes of cyclooxygenase pathway and secretion of prostaglandin E2 and F2alpha by porcine myometrium during luteolysis and early pregnancy.

Franczak A, Kotwica G, Kurowicka B, Oponowicz A, Wocławek-Potocka I, Petroff BK.

Theriogenology. 2006 Sep 15;66(5):1049-56. Epub 2006 Apr 17.

PMID:
16616952
37.
38.

Potential roles of the aryl hydrocarbon receptor in female reproductive senescence.

Valdez KE, Petroff BK.

Reprod Biol. 2004 Nov;4(3):243-58. Review.

PMID:
15592584
39.
41.

Endocrine disruption by indole-3-carbinol and tamoxifen: blockage of ovulation.

Gao X, Petroff BK, Oluola O, Georg G, Terranova PF, Rozman KK.

Toxicol Appl Pharmacol. 2002 Sep 15;183(3):179-88.

PMID:
12383709
42.

Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on serum inhibin concentrations and inhibin immunostaining during follicular development in female Sprague-Dawley rats.

Petroff BK, Gao X, Ohshima K, Shi F, Son DS, Roby KF, Rozman KK, Watanabe G, Taya K, Terranova PF.

Reprod Toxicol. 2002 Mar-Apr;16(2):97-105.

PMID:
11955940
43.

Serous cysts are a benign component of the cyclic ovary in the guinea pig with an incidence dependent upon inhibin bioactivity.

Shi F, Petroff BK, Herath CB, Ozawa M, Watanabe G, Taya K.

J Vet Med Sci. 2002 Feb;64(2):129-35.

44.

Mechanisms of cytokine-induced death of cultured bovine luteal cells.

Petroff MG, Petroff BK, Pate JL.

Reproduction. 2001 May;121(5):753-60.

46.

A review of mechanisms controlling ovulation with implications for the anovulatory effects of polychlorinated dibenzo-p-dioxins in rodents.

Petroff BK, Roby KF, Gao X, Son D, Williams S, Johnson D, Rozman KK, Terranova PF.

Toxicology. 2001 Feb 14;158(3):91-107. Review.

PMID:
11275352
47.
49.

Premixed i.v. admixtures for reducing costs and labor time in a home infusion company.

Petroff BJ.

Am J Health Syst Pharm. 2000 Feb 15;57(4):390. No abstract available.

PMID:
10714977
50.

Developing a care plan.

Filibeck DJ, Petroff B, Sosnowski L, Teahan J.

Am J Health Syst Pharm. 1999 Jul 1;56(13):1348-9. No abstract available.

PMID:
10683135

Supplemental Content

Loading ...
Support Center